Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Operating activities:
Net (loss) income	$ (52,235,000)	$ (240,394,000)	$ 137,240,000
Adjustments to net (loss) income:
Goodwill impairment	102,560,000	236,000,000	0
Impairment of long-lived assets	0	91,904,000	0
Provision for credit losses	912,000	2,058,000	2,527,000
Deferred tax expense (benefit)	3,195,000	(37,650,000)	(8,862,000)
Depreciation and amortization	29,768,000	38,221,000	40,268,000
Amortization of developed technology and backlog	17,520,000	14,558,000	14,558,000
Amortization of debt discount and issuance costs	5,216,000	6,087,000	10,570,000
Gain on extinguishment of debt, net	(14,207,000)	0	0
Gain on debt refinancing	0	0	(457,000)
Equity-based compensation	15,571,000	10,349,000	14,540,000
Change in fair value of contingent consideration	177,000	125,000	2,964,000
Warranty provision	17,273,000	3,163,000	4,666,000
Inventory Valuation Reserves	3,515,000	2,923,000	6,431,000
Inventory reserve	29,516,000	0	0
Other non-cash	(2,032,000)	0	0
Changes in operating assets and liabilities, net of business acquisition:
Accounts receivable	31,008,000	41,423,000	92,800,000
Inventories	52,852,000	(44,787,000)	66,743,000
Income tax receivables	(6,849,000)	(4,112,000)	9,000
Prepaid expenses and other	(25,844,000)	(69,708,000)	(10,840,000)
Accounts payable	(35,868,000)	58,180,000	(37,654,000)
Accrued expenses and other	(54,136,000)	(436,000)	5,325,000
Income tax payable	(540,000)	(863,000)	1,936,000
Lease liabilities	2,202,000	(8,624,000)	1,177,000
Deferred revenue	489,000	55,563,000	(111,986,000)
Other operating assets and liabilities	(18,278,000)	0	0
Net cash provided by operating activities	101,785,000	153,980,000	231,955,000
Investing activities:
Purchase of property, plant and equipment	(21,972,000)	(7,305,000)	(16,989,000)
Acquisition, net of cash acquired	(164,916,000)	0	0
Retirement/disposal of property, plant and equipment	0	34,000	168,000
Cash payments for the acquisition of right-of-use assets	0	(11,276,000)	0
Investment in securities	(1,000,000)	(3,000,000)	0
Sale of equity investment	0	11,975,000	0
Net cash used in investing activities	(187,888,000)	(9,572,000)	(16,821,000)
Financing activities:
Proceeds from issuance of other debt	151,151,000	93,059,000	63,311,000
Proceeds from issuance of convertible notes	345,000,000	0	0
Premium paid on capped call	(35,087,000)	0	0
Fees paid on issuance of convertible notes	(10,434,000)	0	0
Repayments of other debt	(174,392,000)	(97,424,000)	(88,063,000)
Repayments of term loan facility	(233,875,000)	(4,300,000)	(74,300,000)
Repayments of convertible notes	(78,363,000)	0	0
Contingent consideration payments	(1,204,000)	(1,427,000)	(1,200,000)
Other financing	(849,000)	(1,752,000)	(1,509,000)
Net cash used in financing activities	(38,053,000)	(11,844,000)	(101,761,000)
Effect of exchange rate changes on cash and cash equivalent balances	5,999,000	(17,503,000)	1,806,000
Net change in cash and cash equivalents	(118,157,000)	115,061,000	115,179,000
Cash and cash equivalents and restricted cash, beginning of period	364,141,000	249,080,000	133,901,000
Cash and cash equivalents and restricted cash, end of period	$ 245,984,000	$ 364,141,000	$ 249,080,000